<?xml version="1.0" encoding="UTF-8"?>
<ref id="B2-pharmaceutics-11-00021" class="ref">
 <label class="label">2.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Nuchuchua</surname>
    <given-names class="given-names">O.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Nejadnik</surname>
    <given-names class="given-names">M.R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Goulooze</surname>
    <given-names class="given-names">S.C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lješković</surname>
    <given-names class="given-names">N.J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Every</surname>
    <given-names class="given-names">H.A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Jiskoot</surname>
    <given-names class="given-names">W.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Characterization of drug delivery particles produced by supercritical carbon dioxide technologies</article-title>
  <source class="source">J. Supercrit. Fluids</source>
  <year class="year">2017</year>
  <volume class="volume">128</volume>
  <fpage class="fpage">244</fpage>
  <lpage class="lpage">262</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.supflu.2017.06.002</pub-id>
 </element-citation>
</ref>
